Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
Dr Katie Howe, Research Communications Manager at the MS Society charts a vision of a world free from the effects of multiple sclerosis.
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
Here the InBody Clinical Team explain how improved body composition can help fight type 2 diabetes.
Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
New research by the University of East Anglia found that 70% of people with dementia go missing - but why?
According to a new analysis, COVID-19 patients have shown lasting skin problems long after their initial infection has cleared.
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill provides an informative introduction to E. coli and diarrheal disease.
Dr Lucy Chambers, Head of Research Communications at Diabetes UK, provides us with her thoughts on COVID-19 and diabetes, in terms of what do we (not) know.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
Hjalte Hojsgaard, Insulet International, highlights why choice of insulin delivery devices is important, and why access to this life-changing technology is not yet fully utilised in UK diabetes services.
Digital health company Glooko sees a paradigm shift in healthcare with increased remote monitoring and easier access to telehealth.
Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.
InBody Clinical Team describes the relationship between diabetes, one of the most common diseases of the modern age, and muscle mass.
Alex Evans, UK Country Manager for ViCentra B.V., discusses how insulin pump system Kaleido can provide solutions to reduce the practical and emotional burden of living with diabetes.
Jonathan Baker of, GBS Clinic, sheds light on the current extent of our knowledge of Alzheimer’s disease.
Max Halford FBDO CL, Clinical Lead for the Association of British Dispensing Opticians, tells us what we need to know about Diabetic Retinal Screening in this eye health focus.